While 3-Cyclopropylmethoxy-4-difluoromethoxy-benzoic acid (CAS 162401-62-9) is widely recognized as a crucial intermediate in the synthesis of Roflumilast, its utility extends into various research domains. This fine chemical, supplied by manufacturers like NINGBO INNO PHARMCHEM CO.,LTD., offers valuable properties for scientific exploration, particularly in the study of inflammatory and fibrotic diseases.

Research indicates that 3-Cyclopropylmethoxy-4-difluoromethoxy-benzoic acid can attenuate transforming growth factor-β1 (TGF-β1)-induced epithelial-mesenchymal transition (EMT) in cell cultures. EMT is a complex process implicated in the progression of fibrosis and cancer metastasis. By potentially inhibiting this process, the compound shows promise in understanding and developing therapies for fibrotic conditions, such as pulmonary fibrosis, which is often a severe complication in COPD patients.

Moreover, studies have demonstrated its effects in animal models, where it has been shown to reduce bleomycin-induced pulmonary fibrosis in rats. This preclinical evidence highlights the compound's potential therapeutic value. For researchers investigating novel treatments for fibrotic diseases, acquiring high-purity 3-Cyclopropylmethoxy-4-difluoromethoxy-benzoic acid from reliable sources is essential for obtaining accurate and reproducible results. NINGBO INNO PHARMCHEM CO.,LTD. offers this compound, ensuring it meets the stringent requirements for scientific research.

In addition to its direct biological effects, 3-Cyclopropylmethoxy-4-difluoromethoxy-benzoic acid also functions as a valuable reference standard for quality control in the pharmaceutical industry. Its accurate characterization and availability are key to ensuring the purity of related pharmaceutical products, like Roflumilast.

The broader application of this chemical in research underscores the interconnectedness of chemical synthesis, drug development, and disease mechanism studies. By providing access to such specialized compounds, NINGBO INNO PHARMCHEM CO.,LTD. supports scientific advancements, contributing to the development of new diagnostic tools and therapeutic strategies for a range of health conditions.